Hyphens Pharma prices IPO at S$0.26 a share to raise S$13.5m
The company made a net profit of S$6m in 2017, up 16% from 2016 as revenue rose 12% to S$113m
Singapore
HYPHENS Pharma International, which sells specialty pharmaceutical products, is seeking to raise S$13.5 million in net proceeds ahead of a listing on the Singapore Exchange's (SGX) Catalist board.
Hyphens is offering a total of 29.6 million shares (9.9 per cent of the company) at S$0.26 apiece. Cornerstone investors will take up another 10.1 per cent stake in Hyphens.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Swiss-Asia Financial Services fined S$2.5 million for money-laundering rule breaches
Singapore-based Princeton Digital gets green loan for US$1.5 billion Asia AI hub
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Apple is working on its own AI chip for data centres: WSJ
European oil giants consider shifting their listings to the US
ExxonMobil sees Hess arbitration dragging into 2025, CEO says